Another compound that restores p53 transcriptional activity in mut-p53 glioma cells is P53R3, which has demonstrated superior cancer cell specificity and the ability to target a wider range of p53 mutants than PRIMA-1 [341] (Table 1). This evidence concerns the gene TP53 and glioma.